2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on Recurrent Ovarian Cancer: Does the Addition of Mirvetuximab Soravtansine (MIRV) to Bevacizumab Have Promising Activity in FRα Platinum Agnostic Disease?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Oliver Dorigo
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Oliver Dorigo
73 views
August 18, 2020
Comments 0
Login to view comments.
Click here to Login
GYN